Loading insider details...
Beta
Latest Form 4 (Jun 9, 2026): Grant/Award of 30,000 CHRS shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 9, 2026 | Coherus Oncology, Inc. (CHRS) | Grant/Award | 30,000 | n/a |
| May 18, 2026 | TriSalus Life Sciences, Inc. (TLSI) | Purchase | 60,000 | $151.8K |
| May 15, 2026 | TriSalus Life Sciences, Inc. (TLSI) | Grant/Award | 37,602 | n/a |
| Jun 27, 2025 | TriSalus Life Sciences, Inc. (TLSI) | Grant/Award | 15,000 | n/a |
| Jun 13, 2025 | Coherus Oncology, Inc. (CHRS) | Grant/Award | 112,000 | n/a |
| May 28, 2025 | Coherus BioSciences, Inc. (CHRS) | Sale | 99,988 | $73.9K |
| Feb 11, 2025 | TriSalus Life Sciences, Inc. (TLSI) | Other (see footnotes) | 44,750 | n/a |
| Dec 19, 2024 | TriSalus Life Sciences, Inc. (TLSI) | Grant/Award | 25,188 | $100.0K |
| Nov 25, 2024 | TriSalus Life Sciences, Inc. (TLSI) | Purchase | 5,000 | $22.8K |
| Nov 23, 2024 | TriSalus Life Sciences, Inc. (TLSI) | Purchase | 2,040 | $8.5K |